Acyclovir in combination with zidovudine does not prolong survival in advanced HIV disease

Antiviral Therapy

Volumn 2, Issue 2, 1997, Pages 71-77

  Erbelding, Emily J ^a   Chaisson, Richard E ^a   Gallant, Jod E ^a   Moore, Richard D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ZIDOVUDINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL;

ACYCLOVIR; ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; ZIDOVUDINE;

EID: 0030962149     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Mitsuya H & Broder S. Strategies for antiviral therapy in AIDS. Nature 1987; 325:773-778.
2. Smith MS & Pagano JS. Inhibition of human immunodeficiency virus type 1 replication by guanosine analogues and lack of synergistic antiviral effect of acyclovir with 3′-azido-3′-deoxythymidine. Antiviral Chemistry Chemotherapy 1991; 2:29-34.
3. Cooper DA, Pehrson PO, Pederson C, Moroni M, Oksenhendler E, Rozenbaum W, Clumeck N, Faber V, Wolfgang S, Hirschel B, Farthing C, Doherty R & Yeo JM. The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind, randomized trial. AIDS 1993; 7:197-207.
4. Youle MS, Gazzard BG, Johnson M, Cooper DA, Hoy JF, Busch H, Ruf B, Griffiths PD, Stephenson SL, Dancox M & Bell AR. Effects of high-dose acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study. AIDS 1994; 8:641-649.
5. Collier AC, Schoenfeld DA, Bourland D, Hirsch M, Davis LG & Corey L. Prospective comparative study of acyclovir (ACV) and zidovudine (ZDV) versus ZDV alone in patients with AIDS. Abstracts of the 2nd National Conference on Human Retroviruses and Related Infections, January 29-February 2 1995; Abstract 383. p125.
6. Stein DS, Graham NMH, Park LP, Hoover DR, Phair JP, Detels R, Ho M & Saah AJ. The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival: analysis of data in the multicenter AIDS cohort study. Annals of Internal Medicine 1994; 121:100-108.
7. Gallant JE, Moore RD, Keruly J, Richman DD & Chaisson RE. Lack of association between acyclovir use and survival in patients with advanced HIV diseases treated with zidovudine. Journal of Infectious Diseases 1995; 172:346-352.
8. Torres R, Neaton J, Wentworth D, Barr M, Abrams D, Sherer R, Ward T & Sampson J. Lack of association between acyclovir use and survival in an observational cohort enrolled by the Community Program for Clinical Research on AIDS. Abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections January 28-February 1 1996; Abstract 367.p121.
9. Golden MP, Kim S, Hammer SM, Ladd EA, Schaffer PA, DeLuca N & Albrecht MA. Activation of HIV by herpes simplex virus. Journal of Infections Diseases 1992; 166:494-449.
10. Mosca JD, Bednarik DP, Raj NBK, Rosen CA, Sodroski JG, Haseltine NA & Pitha PM. Herpes simplex virus type I can reactivate transcription of latent human immunodeficiency virus. Nature 1987; 325:67-70.
11. Ostrove JM, Leonard J, Weck KE, Rabson AB & Gendelman HE. Activation of the human immunodeficiency virus by herpes simplex virus type I. Journal of Virology 1987; 61:3726-3732.
12. Heng MCY, Heng SY & Allen SG. Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1. Lancet 1995; 343:255-258.
13. Mole L, Ripich S, Margolis D & Holodniy M. Plasma HIV RNA levels are increased during active herpes simplex virus infection. Abstracts of the 2nd National Conference on Human Retroviruses and Related Infections January 29-February 2 1995; Abstract 239. p98.
14. Chaisson RE, Keruly JC & Moore RD: Race, sex, drug use, and the progression of human immunodeficiency virus disease. New England Journal Medicine 1995; 333:751-756.
15. McGrath BJ & Newman CL. Genital herpes simplex infections in patients with the acquired immunodeficiency syndrome. Pharmacotherapy 1994; 14:529-542.
16. Dong BJ & Luber AD. Survey of antiretroviral selection by physicians and HIV-infected persons. Abstracts of the XI International Conference on AIDS July 7-12 1996; Abstract Mo.B.1136. p78.
17. Balfour HH Jr, Benson C, Braun J, Cassens B, Erice A, Friedman-Kien A, Klein T, Polsky B & Safrin S. Management of acyclovir-resistent herpes simplex and varicella-zoster infections. Journal of Acquired Immune Deficiency Syndromes 1994; 7:254-260.